Thakur Gurjeet Singh - Böcker

Advances in Brain Tumor Therapy: From Molecular Mechanisms to Clinical Practice explores the evolving landscape of brain tumor treatment, addressing challenges posed by these rare yet impactful malignancies. The book highlights significant improvements in patient prognoses due to advances in targeted therapies and immunotherapies while also recognizing the limitations of current treatment options. The content examines brain tumor epidemiology, incidence, risk factors, and survival rates followed by an extensive overview of existing therapeutic approaches, including clinical trials, targeted treatments, immunotherapies, and systemic therapies. It also delves into the critical signaling pathways that drive tumor biology and implications for future strategies.This book serves as an essential resource for healthcare professionals, clinical researchers, medical students, and scientists, bridging the gap between basic science and clinical practice. By providing insights into the latest advancements and emerging technologies, it equips readers with the knowledge necessary to navigate the complexities of brain tumor therapy and prepare for future innovations.Provides an extensive examination of brain tumors, covering epidemiology, classification, pathogenesis, and current treatment modalitiesEmphasizes innovative treatment techniques and future research opportunities, preparing readers for potential breakthroughs in brain tumor therapy and the challenges that lie ahead in the fieldBridges the gap between fundamental research and clinical applications by detailing the latest advancements in therapeutic approaches, including targeted therapies, immunotherapies, and personalized medicine strategies

The World Stroke Organization reports that “stroke has already reached epidemic proportions. Globally1 in 4 adults over the age of 25 will have a stroke in their lifetime. 12.2 million people worldwide will have their first stroke this year, and 6.5 million will die as a result.” Ischemic strokes are the most common type of stroke, with about 87% of all strokes being ischemic strokes.This new volume addresses this epidemic by presenting detailed studies on ischemic injury, with emphasis on the molecular-level mechanisms and the role of signaling pathways in the body, their structure, and their mechanism of action. The book focuses on molecular pharmacology plans and explains the new areas of research on the discovery of therapeutic molecules that can be used for combating this life-threatening disease. The authors discuss stroke occurrence at different stages of life as well as sex-based differences in its treatment. They cover aspects of the clinical treatment and diagnosis of patients with cardiovascular events, including in-depth information on the prevention, evaluation, therapy selection, result projection, and long-term course of the disease in affected patients. They also detail the involvement of platelets, neurotransmitters, renin-angiotensin-aldosterone system, and vitamin D in ischemic injury.

The study of free radicals and their role in the development and progression of diseases has gained importance in recent decades, providing invaluable insights into the fundamental mechanisms of pathology. This new book describes the role of free radicals and their deleterious impact on human health, offering a deep understanding of the molecular and cellular processes involved in disease progression and helping to bridge the gap between scientific research and its applicability.The chapters provide an examination of different diseases that are seen to be caused by harmful free radicals. The book also unravels the origin of free radicals and their intricate relationship with vital biomolecules. Through an examination of the diverse diseases affected by free radicals, the book uncovers their pivotal role in the pathology of conditions such as cancer, cardiovascular disorders, neurodegenerative diseases, diabetes, dyslipidemia, stroke, epilepsy, and others. The chapters also establish the delicate balance of the body’s antioxidant defense system, which plays a crucial role in mitigating the harmful effects of free radicals on human health.

Endocrine and metabolic diseases pose significant challenges to public health worldwide, affecting millions of individuals, impacting their quality of life. This new book offers an exploration of therapeutic strategies and advancements in the management of endocrine and metabolic disorders. Each chapter delves into specific disorders, discussing their pathophysiology, clinical manifestations, and cutting-edge therapeutic strategies.

Addressing the growing need for innovative and effective treatments for metabolic and endocrine disorders, which affect millions of individuals worldwide, this volume explore the cutting-edge developments in the field, offering a comprehensive overview of emerging therapies that promise to revolutionize patient care. From gene therapy and personalized medicine to advancements in pharmacology and biotechnology, this new book encapsulates the future of treatment modalities that promise to revolutionize patient care. Providing a comprehensive review of emerging therapies, supported by robust scientific evidence and clinical trials, the book delves into the mechanisms of action, potential benefits, and practical applications of these next-gen therapies for metabolic and endocrine disorders, offering healthcare professionals a valuable resource to enhance their practice.Taking a forward-thinking approach, the authors not only discuss the current state of next-gen therapies but also envision future directions and innovations that could further transform the landscape of metabolic and endocrine disorder management. Chapters cover novel therapeutic approaches to metabolic syndromes, such as single-cell transcriptomics, therapeutic approaches to newer classes of drugs and treatments for type 2 diabetes mellitus, the use of artificial intelligence and the internet of things in diagnosis and management of diabetes mellitus, to name a few. The book offers state-of-the-art therapeutic approaches for such health issues as thyroid disorders, type 2 diabetes mellitus, diabetic gastroparesis, high cholesterol, phenylketonuria, cerebrovascular diseases, chronic renal failure, adrenal metabolic disorders, Gaucher disease, Parkinson disease, etc.An essential reference, guiding healthcare professionals towards more effective, personalized, and innovative treatments, this volume will inspire ongoing research and clinical advancements, ultimately leading to improved outcomes and quality of life for patients worldwide.

The new book, Precision Nutrition and Endocrine Health: From Pregnancy to Chronic Diseases, unites the latest insights and research on nutrition and health from experts worldwide. It offers a comprehensive and holistic exploration of the pivotal relationship between nutrition and endocrine health, recognizing the profound impact of nutrition from the earliest stages of life onward. This understanding is fundamental to enhancing health interventions and outcomes globally.The book covers health from various aspects that include nutrition, endocrinology, and related fields, presenting cutting-edge research and practical strategies. It addresses the continuum of endocrine health, beginning with prenatal nutrition and maternal health, and extending to the prevention and management of chronic diseases such as diabetes, thyroid disorders, and metabolic syndromes.Each chapter provides a clinical perspective backed by the latest scientific evidence and best clinical practices. It covers topics such as endocrine diseases in pregnancy, hormone replacement therapy, impact of diet on gut microbiome and metabolic disorders, natural phytochemicals and novel phyto-nanotherapeutics targeting approaches for diabetes mellitus, etc. It also covers nutritional approaches to management of various metabolic disorders, obesity, and kidney diseases.By offering insights into these complex conditions, the book contributes to better health outcomes for individuals worldwide affected by endocrine and metabolic diseases. It will serve as an invaluable reference for the medical community, advancing knowledge and improving patient care.